Structures by: Li T. D.
Total: 10
C20H17N3O3
C20H17N3O3
CrystEngComm (2011) 13, 21 6365
a=5.707(3)Å b=8.886(5)Å c=9.503(5)Å
α=71.733(5)° β=79.378(9)° γ=84.199(9)°
C20H17ClN2O4
C20H17ClN2O4
CrystEngComm (2011) 13, 21 6365
a=5.7108(17)Å b=9.011(3)Å c=9.451(3)Å
α=70.550(3)° β=81.022(4)° γ=85.818(3)°
C20H19ClN2O
C20H19ClN2O
CrystEngComm (2011) 13, 21 6365
a=5.441(4)Å b=8.892(6)Å c=9.554(7)Å
α=74.542(8)° β=82.346(8)° γ=76.224(8)°
C11H10N4
C11H10N4
CrystEngComm (2013) 15, 37 7430
a=7.0582(13)Å b=17.577(3)Å c=8.5676(16)Å
α=90.00° β=101.257(2)° γ=90.00°
C11H16N4O3
C11H16N4O3
CrystEngComm (2013) 15, 37 7430
a=13.554(2)Å b=21.511(3)Å c=4.5170(7)Å
α=90.00° β=90.00° γ=90.00°
9-{4-[(<i>E</i>)-2-(4,6-Dimethyl-1,3,5-triazin-2-yl)ethenyl]phenyl}-9<i>H</i>- carbazole
C25H20N4
Acta Crystallographica Section E (2009) 65, 9 o2095
a=8.0415(8)Å b=15.716(2)Å c=16.0980(10)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-Tetrakis(2-hydroxy-5- methylbenzyl)ethane-1,2-diamine dimethylformamide disolvate
C34H40N2O4,2(C3H7NO)
Acta Crystallographica Section E (2011) 67, 6 o1438
a=11.574(2)Å b=6.3557(12)Å c=26.343(5)Å
α=90.00° β=94.939(3)° γ=90.00°
C44H42Cd2Cl2N16O
C44H42Cd2Cl2N16O
Crystal Growth & Design (2010) 10, 1 25
a=11.924(2)Å b=11.924(2)Å c=14.885(6)Å
α=90.00° β=90.00° γ=90.00°
C44H42Br2Cd2N16O
C44H42Br2Cd2N16O
Crystal Growth & Design (2010) 10, 1 25
a=11.9525(6)Å b=11.952Å c=15.0052(7)Å
α=90.00° β=90.00° γ=90.00°
C11H14N4O2
C11H14N4O2
CrystEngComm (2013) 15, 37 7430
a=14.032(8)Å b=19.114(10)Å c=4.625(3)Å
α=90.00° β=90.00° γ=90.00°